KEY FEATURES
| Full Name | Plasminogen Activator Inhibitor 1 |
|---|---|
| Synonym | SERPINE1;PAI;PAI-1;PLANH1;Endothelial Plasminogen Activator Inhibitor; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 125-8000pg/mL |
| Sensitivity | 55pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PAI1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PAI1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PAI1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PAI1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PAI1. You can calculate the concentration of Human PAI1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PAI1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 415.04 | 1065.32 | 3310.89 | 408.77 | 1054.66 | 3604.3 |
| Standard deviation | 24.65 | 57.53 | 151.64 | 27.8 | 52.73 | 167.6 |
| CV(%) | 5.94 | 5.4 | 4.58 | 6.8 | 5 | 4.65 |
RECOVERY
The recovery of Human PAI1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-98 | 92 |
| EDTA plasma (n=8) | 90-103 | 95 |
| Cell culture media (n=8) | 87-98 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PAI1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with SERPINE1 ELISA Kits
| TGFB1 ELISA Kit | publications with SERPINE1 and TGFB1 |
| SMAD4 ELISA Kit | publications with SERPINE1 and SMAD4 |
| HIF1A ELISA Kit | publications with SERPINE1 and HIF1A |
| EGF ELISA Kit | publications with SERPINE1 and EGF |
| PLG ELISA Kit | publications with SERPINE1 and PLG |
| PLAT ELISA Kit | publications with SERPINE1 and PLAT |
| PLAU ELISA Kit | publications with SERPINE1 and PLAU |
| VTN ELISA Kit | publications with SERPINE1 and VTN |
| ALB ELISA Kit | publications with SERPINE1 and ALB |
Pathways associated with SERPINE1 ELISA Kit
| Adipogenesis Pathway | Adipogenesis Pathway |
| BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression Pathway | BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression Pathway |
| Blood Clotting Cascade Pathway | Blood Clotting Cascade Pathway |
| Chagas Disease (American Trypanosomiasis) Pathway | Chagas Disease (American Trypanosomiasis) Pathway |
| Circadian Clock Pathway | Circadian Clock Pathway |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Direct P53 Effectors Pathway | Direct P53 Effectors Pathway |
Diseases associated with SERPINE1 ELISA Kit
| Cardiovascular Diseases | publications with SERPINE1 and Cardiovascular Diseases |
| Thrombosis | publications with SERPINE1 and Thrombosis |
| Inflammation | publications with SERPINE1 and Inflammation |
| Heart Diseases | publications with SERPINE1 and Heart Diseases |
| Necrosis | publications with SERPINE1 and Necrosis |
| Obesity | publications with SERPINE1 and Obesity |
| Atherosclerosis | publications with SERPINE1 and Atherosclerosis |
| Hypertension | publications with SERPINE1 and Hypertension |
| Fibrosis | publications with SERPINE1 and Fibrosis |
| Nervous System Diseases | publications with SERPINE1 and Nervous System Diseases |
Organs/Tissues associated with SERPINE1 ELISA Kit
| Blood | publications with SERPINE1 and Blood |
| Vascular | publications with SERPINE1 and Vascular |
| Heart | publications with SERPINE1 and Heart |
| Kidney | publications with SERPINE1 and Kidney |
| Muscle | publications with SERPINE1 and Muscle |
| Liver | publications with SERPINE1 and Liver |
| Connective Tissue | publications with SERPINE1 and Connective Tissue |
| Lung | publications with SERPINE1 and Lung |
| Adipose Tissue | publications with SERPINE1 and Adipose Tissue |
| Brain | publications with SERPINE1 and Brain |